This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Grant Funding opportunity- Biomedical Catalyst 2022 Round 1: Industry-led R&D










TheHill’s team is now open for submitting a joint projects , or to write /review your proposal. We have a highly skilled team with long experience in grant writing and we can explore together the opportunity to partner with your organisation as a healthcare service provider.
Please contact [email protected] by Tuesday 10th of May

Grantor: InnovateUK

Funding type: Grant

Grant award: £150,000 – £2M  

Closing date: 25th May 2022 

Innovate UK, part of UK Research and Innovation will invest up to £15 million in projects to support UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes. 

Your project can focus on: 

  • disease prevention and proactive management of health and chronic conditionsΩ 
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes 
  • tailored treatments that either change the underlying disease or offer potential cures 
  • the development of digital health technologies 

This list is not intended to be exhaustive. 


The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility. Link to InnovateUK website here. 

The aim of this industry-led R&D competition is to support the development of innovative solutions to health and healthcare challenges. 


Your project can include: 

  • experimental evaluation (at laboratory scale) 
  • use of in vitro and in vivo models to evaluate proof of concept or safety 
  • exploring potential production mechanisms 
  • prototyping 
  • product development planning 
  • intellectual property protection 
  • a demonstration of clinical utility and effectiveness 
  • a demonstration of safety and efficacy (including phase 1 and 2 clinical trials) 
  • regulatory planning 


Your project can align with one or more of the following Innovation areas: 


advanced therapies (gene and cell therapies) 

diagnostic, medical technology and devices 

digital health 

independent living and wellbeing 

precision medicine 

preclinical technologies and drug target discovery 

therapeutic and medicine development 

This list is not intended to be exhaustive. 


Please contact  [email protected]  by  Tuesday 10th of May. 

More details of Biomedical Catalyst 2022 Round 1: Industry-led R&D please see here